Unknown

Dataset Information

0

Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death.


ABSTRACT: Dravet syndrome is a catastrophic, pharmacoresistant epileptic encephalopathy. Disease onset occurs in the first year of life, followed by developmental delay with cognitive and behavioral dysfunction and substantially elevated risk of premature death. The majority of affected individuals harbor a loss-of-function mutation in one allele of SCN1A, which encodes the voltage-gated sodium channel NaV1.1. Brain NaV1.1 is primarily localized to fast-spiking inhibitory interneurons; thus the mechanism of epileptogenesis in Dravet syndrome is hypothesized to be reduced inhibitory neurotransmission leading to brain hyperexcitability. We show that selective activation of NaV1.1 by venom peptide Hm1a restores the function of inhibitory interneurons from Dravet syndrome mice without affecting the firing of excitatory neurons. Intracerebroventricular infusion of Hm1a rescues Dravet syndrome mice from seizures and premature death. This precision medicine approach, which specifically targets the molecular deficit in Dravet syndrome, presents an opportunity for treatment of this intractable epilepsy.

SUBMITTER: Richards KL 

PROVIDER: S-EPMC6112713 | biostudies-other | 2018 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Selective Na<sub>V</sub>1.1 activation rescues Dravet syndrome mice from seizures and premature death.

Richards Kay L KL   Milligan Carol J CJ   Richardson Robert J RJ   Jancovski Nikola N   Grunnet Morten M   Jacobson Laura H LH   Undheim Eivind A B EAB   Mobli Mehdi M   Chow Chun Yuen CY   Herzig Volker V   Csoti Agota A   Panyi Gyorgy G   Reid Christopher A CA   King Glenn F GF   Petrou Steven S  

Proceedings of the National Academy of Sciences of the United States of America 20180803 34


Dravet syndrome is a catastrophic, pharmacoresistant epileptic encephalopathy. Disease onset occurs in the first year of life, followed by developmental delay with cognitive and behavioral dysfunction and substantially elevated risk of premature death. The majority of affected individuals harbor a loss-of-function mutation in one allele of <i>SCN1A</i>, which encodes the voltage-gated sodium channel Na<sub>V</sub>1.1. Brain Na<sub>V</sub>1.1 is primarily localized to fast-spiking inhibitory inte  ...[more]

Similar Datasets

| S-EPMC9291096 | biostudies-literature
| S-EPMC3437823 | biostudies-other
| S-EPMC6952031 | biostudies-literature
2021-11-29 | GSE171191 | GEO
| S-EPMC5512282 | biostudies-literature
| S-EPMC10191256 | biostudies-literature
| S-EPMC8851461 | biostudies-literature
| S-EPMC6555418 | biostudies-literature
| S-EPMC6075536 | biostudies-literature
| S-EPMC7096149 | biostudies-literature